natgillin/translations-raw huggingface dataset:
If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed Clopidogrel Acino in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever. 
Ako ste imali jaku bol u prsištu (nestabilna angina ili srčani udar), liječnik Vam može propisati Clopidogrel Acino u kombinaciji s acetilsalicilatnom kiselinom, tvari prisutnom u mnogim lijekovima za ublažavanje boli i snižavanje temperature.
Because the active metabolite is formed by CYP450 enzymes, some of which are polymorphic or subject to inhibition by other medicinal products, not all patients will have adequate platelet inhibition. 
Budući da se aktivni metabolit klopidogrela stvara pomoću enzima CYP450, od kojih su neki polimorfni ili podložni inhibiciji od strane drugih lijekova, neće svi bolesnici imati adekvatnu inhibiciju trombocita.
However, clopidogrel and ASA have been administered together for up to one year (see section 
Međutim, klopidogrel i ASK su se istodobno primjenjivali u trajanju do jedne godine (vidjeti dio 5.1).
• You should also tell your doctor immediately if you develop a medical condition (also known as Thrombotic Thrombocytopenic Purpura or TTP) that includes fever and bruising under the skin that may appear as red pinpoint dots, with or without unexplained extreme tiredness, confusion, yellowing of the skin or eyes (jaundice) (see section 4). 
• Također, odmah obavijestite svog liječnika ukoliko se pojavi medicinsko stanje (koje se naziva "trombotična trombocitopenična purpura" ili "TTP") sa simptomima koji uključuju vrućicu i potkožne modrice koji se mogu pojaviti kao crvene točkice, sa ili bez neobjašnjivog teškog umora, zbunjenosti i žute boje kože ili očiju (žutica) (pogledajte dio 4.).
Due to the irreversible binding, platelets exposed are affected for the remainder of their lifespan (approximately 7 - 10 days) and recovery of normal platelet function occurs at a rate consistent with platelet turnover. 
Zbog ireverzibilnog vezanja, izloženi trombociti zahvaćeni su ovim učinkom do kraja svog životnog vijeka (oko 7-10 dana), a povrat normalne funkcije trombocita događa se brzinom koja odgovara brzini stvaranja novih trombocita.
SPECIAL STORAGE CONDITIONS Store in the original blister in order to protect from moisture. 
POSEBNE MJERE ČUVANJA Čuvati u originalnom blisteru radi zaštite od vlage.
The safety and efficacy of clopidogrel have been evaluated in 5 double-blind studies involving over 88,000 patients: the CAPRIE study, a comparison of clopidogrel to ASA, and the CURE, CLARITY, COMMIT and ACTIVE-A studies comparing clopidogrel to placebo, both medicinal products given in combination with ASA and other standard therapy. 
Sigurnost i djelotvornost klopidogrela procijenjeni su u 5 dvostruko slijepa ispitivanja u koja je bilo uključeno više od 88 000 bolesnika: ispitivanje CAPRIE, u kojem se klopidogrel uspoređivao s ASK te CURE, CLARITY, COMMIT i ACTIVE-A ispitivanja, u kojima se klopidogrel uspoređivao splacebom, s tim da su oba lijeka davana u kombinaciji s ASK i drugom standardnom terapijom.
In patients with acute ST-segment elevation MI, safety and efficacy of clopidogrel have been evaluated in 2 randomised, placebo-controlled, double-blind studies, CLARITY and COMMIT. 
U bolesnika s akutnim infarktom miokarda sa ST elevacijom (STEMI), sigurnost i djelotvornost klopidogrela procijenjena je u 2 randomizirane, dvostrukoslijepe, placebom kontrolirane studije, CLARITY i COMMIT.
Alu/Alu blisters containing 14, 28, 30, 50, 84, 90 and 100 film-coated tablets packed in cardboard cartons. 
Al/Al blisteri koji sadrže 14, 28, 30, 50, 84, 90 i 100 filmom obloženih tableta u kartonskoj kutiji.
If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Clopidogrel Acino. 
Ako ste trudni ili sumnjate na trudnoću, obavjestite svog liječnika ili ljekarnika prije nego što uzmete Klopidogrel Acino.
If you have experienced severe chest pain (unstable angina or heart attack), your doctor may give you 300 mg of Clopidogrel Acino (4 tablets of 75 mg) once at the start of treatment. 
Ako ste imali jake bolove u prsištu (nestabilna angina ili srčani udar), liječnik Vam u početku liječenja može jednokratno dati 300 mg lijeka Klopidogrel Acino (4 tablete po 75 mg).
The CAPRIE study included 19,185 patients with atherothrombosis as manifested by recent myocardial infarction (< 35 days), recent ischaemic stroke (between 7 days and 6 months) or established peripheral arterial disease (PAD). 
Studija CAPRIE uključivala je 19 185 bolesnika s aterotrombozom koja se manifestirala kao nedavni infarkt miokarda (<35 dana), nedavni ishemijski moždani udar (između 7 dana i 6 mjeseci) ili utvrđena bolest perifernih arterija (BPA).
Overall, clopidogrel 75 mg/day was comparable to ASA 325 mg/day in CAPRIE regardless of age, gender and race. 
Sveukupno je, u ispitivanju CAPRIE, 75 mg/dozi klopidogrela bilo usporedivo s 325 mg/dan ASK, bez obzira na dob, spol ili rasu
The major exclusion criteria for patients were documented peptic ulcer disease within the previous 6 months; prior intracerebral hemorrhage; significant thrombocytopenia (platelet count < 50 x 109/l); requirement for clopidogrel or oral anticoagulants (OAC); or intolerance to any of the two compounds. 
Glavni kriterij za isključivanje bolesnika bili su dokumentirani peptički ulkus unutar zadnjih 6 mjeseci, prethodno intracerbralno krvarenje, značajna trombocitopenija (broj trombocita <50 x 109/l), potreba za klopidogrelom ili oralnim antikoagulansima ili netolerancija prema bilo kojoj od dvije djelatne tvari.
Then, the recommended dose is one 75 mg tablet of Clopidogrel Acino per day as described above. 
Acino je jedna tableta od 75 mg dnevno, kao što je opisano iznad.
Do not use Clopidogrel Acino if you notice any visible sign of damage of blister or film-coated tablets. 
Acino ako ste uočili vidljive znakove oštećenja blistera ili filmom obloženih tableta.
If you stop taking Clopidogrel Acino 
Ako prestanete uzimati Klopidogrel Acino
EU/1/09/532/001 - 007 
ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/09/532/001 - 007
NAME OF THE MARKETING AUTHORISATION HOLDER Acino AG 
NOSITELJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET Acino AG
If you forget to take a dose of Clopidogrel Acino, but remember within 12 hours of your usual time, take your tablet straight away and then take your next tablet at the usual time. 
Acino, ali se toga sjetite unutar 12 sati od uobičajenog vremena uzimanja, odmah uzmite tabletu, a sljedeću tabletu uzmite u uobičajeno vrijeme.
In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke. 
U odraslih bolesnika s fibrilacijom atrija koji imaju najmanje jedan faktor rizika za krvožilne događaje, nisu podobni za terapiju antagonistima vitamina K (VKA) te imaju nizak rizik od krvarenja, klopidogrel je indiciran u kombinaciji s ASK za prevenciju aterotrombotičkih i tromboembolijskih događaja, uključujući moždani udar.
What Clopidogrel Acino is and what it is used for What you need to know before you take Clopidogrel Acino 
Što je Klopidogrel Acino i za što se koristi Što morate znati prije nego počnete uzmati Klopidogrel Acino Kako uzimati Klopidogrel Acino Moguće nuspojave
Clopidogrel Acino is taken by adults to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death). 
Klopidogrel Acino uzimaju odrasli za sprječavanje stvaranja krvnih ugrušaka (tromba) u otvrdnutim krvnim žilama (arterijama), a taj poremećaj zove se aterotromboza i može dovesti do aterotrombotičkih događaja (kao što su moždani udar, srčani udar ili smrt).
Clopidogrel Acino 75 mg film-coated tablets are white to off-white, marbled, round and biconvex. 
Klopidogrel Acino 75 mg filmom obložene tablete su bijele do gotovo bijele, mramorirane, okrugle i bikonveksne tablete.
ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy. 
- Akutni infarkt miokarda s elevacijom ST-segmenta, u kombinaciji s ASK u medikamentozno liječenih bolesnika pogodnih za liječenje trombolitičkom terapijom.
Mean peak plasma levels of unchanged clopidogrel (approximately 2.2 - 2.5 ng/ml after a single 75 mg oral dose) occurred approximately 45 minutes after dosing. 
Srednje vršne razine nepromijenjenog klopidogrela u plazmi (oko 2,2 - 2,5 ng/ml nakon jednokratne oralne doze od 75 mg), postiže se otprilike 45 minuta nakon uzimanja lijeka.
If you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain. 
• ako imate poremećaj koji izaziva krvarenje, kao što je, primjerice, želučani čir ili krvarenje u mozgu
The clinically relevant adverse reactions observed in the CAPRIE, CURE, CLARITY and COMMIT studies are discussed below. 
Klinički značajne nuspojave primjećene u CAPRIE, CURE, CLARITY i COMMIT ispitivanjima opisane su u tekstu u nastavku.
What Clopidogrel Acino looks like and contents of the pack 
Acino izgleda i sadržaj pakiranja
The primary endpoint was the occurrence of the composite of an occluded infarct-related artery on the predischarge angiogram, or death or recurrent MI before coronary angiography. 
Primarni kompozitni ishod bio je pojava okludirane koronarne arterije koja je najvjerojatnije dovela do infarkta miokarda na angiogramu učinjenom prije otpusta, smrt ili ponovljeni infarkt miokarda prije koronarne angiografije.
After repeated doses of 75 mg clopidogrel per day for 10 days in patients with severe hepatic impairment, inhibition of ADP-induced platelet aggregation was similar to that observed in healthy subjects. 
Nakon ponovljenih dnevnih doza klopidogrela od 75 mg tijekom 10 dana, u bolesnika s teško oštećenom funkcijom jetre, inhibicija ADP-om inducirane agregacije trombocita bila je slična u usporedbi sa zdravim ispitanicima.
C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING 
OSTALI UVJETI I ZAHTJEVI ZA STAVLJANJE LIJEKA U PROMET
Other medicines and Clopidogrel Acino 
Drugi lijekovi i Clopidogrel
Fifteen percent (15.0%) of patients in the clopidogrel group and 21.7% in the placebo group reached the primary endpoint, representing an absolute reduction of 6.7% and a 36% odds reduction in favour of clopidogrel (95% CI: 24, 47%; p < 0.001), mainly related to a reduction in occluded infarct-related arteries. 
Petnaest posto (15,0%) bolesnika u skupini s klopidogrelom i 21,7% u skupini s placebom dostigli su primarni ishod, što predstavlja apsolutno smanjenje od 6,7% i smanjenje izgleda (od engl. odds reduction) od 36% u korist klopidogrela (95% CI: 24, 47%; p<0,001), većinom povezano sa smanjenjem okluzije arterija povezanih s infarktom.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 28 July 2009 
DATUM PRVOG ODOBRENJA/DATUM OBNOVE ODOBRENJA
Jaundice; severe abdominal pain with or without back pain; fever, breathing difficulties sometimes associated with cough; generalised allergic reactions (for example, overall sensation of heat with sudden general discomfort until fainting); swelling in the mouth; blisters of the skin; skin allergy; sore mouth (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscular pain; changes intaste of food. 
Vrlo rijetke nuspojave (mogu se javiti u manje od 1 na 10 000 osoba): žutica; jaka bol u trbuhu s ili bez bolova u leđima; vrućica, teškoće pri disanju, ponekad povezane s kašljem; generalizirane alergijske reakcije (primjerice, sveukupni osjećaj vrućine s iznenadnom općom nelagodom do nesvjestice); oticanje u ustima; mjehurići na koži; kožne alergijske reakcije; upala u usnoj šupljini (stomatitis); pad krvnoga tlaka; zbunjenost; halucinacije; bol u zglobovima; bol u mišićima; poremećaj okusa hrane.
After a single oral dose of 75 mg, clopidogrel has a half-life of approximately 6 hours. 
Nakon jednokratne peroralne primjene klopidogrela u dozi od 75 mg, poluvijek klopidogrela iznosio je otprilike 6 sati.
QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 75 mg of clopidogrel (as besilate). 
KVALITATIVNI I KVANTITATIVNI SASTAV Jedna filmom obložena tableta sadrži 75 mg klopidogrela (u obliku klopidogrelbesilata).
However, if you are concerned by your bleeding, you should contact your doctor straightaway (see section 2). 
Ukoliko ste ipak zabrinuti zbog krvarenja, odmah obavijestite svog liječnika (pogledajte dio 2.).
As with other antiplatelet agents, clopidogrel should be used with caution in patients who may be at risk of increased bleeding from trauma, surgery or other pathological conditions and in patients receiving treatment with ASA, heparin, glycoprotein IIb/IIIa inhibitors or nonsteroidal anti-inflammatory drugs (NSAIDs) including Cox-2 inhibitors, or selective serotonin reuptake inhibitors (SSRIs), or other medicinal products associated with bleeding risk such as pentoxifylline (see section 4.5). 
Kao i u slučaju drugih antitrombocitnih lijekova, klopidogrel s oprezom treba davati bolesnicima koji su izloženi povećanom riziku od krvarenja zbog povrede, kirurških zahvata ili drugih patoloških stanja te bolesnicima koji se liječe s ASK, heparinom, inhibitorima glikoproteina IIb/IIIa ili nesteroidnim protuupalnim lijekovima (NSAIL), uključujući Cox-2 inhibitore ili selektivne inhibitore ponovne pohrane serotonina (SSRI) ili druge lijekove povezane s rizikom od krvarenja kao što je pentoksifilin (vidjeti dio 4.5).
If you think any of these apply to you, or if you are in any doubt at all, consult your doctor before taking Clopidogrel Acino. 
Ako se bilo što od navedenog odnosi na Vas, ili niste sigurni, obratite se svom liječniku prije uzimanja lijeka Clopidogrel Acino.
Monitoring for signs of hypersensitivity in patients with a known allergy to thienopyridines is advised. 
Preporučuje se nadzirati bolesnika s poznatom alergijom na tienopiridine na znakove preosjetljivosti.
Clopidogrel is a product, one of whose metabolites is an inhibitor of platelet aggregation. 
Klopidogrel je predlijek, čiji je jedan metabolit inhibitor agregacije trombocita.
The pharmacokinetics of the active metabolite of clopidogrel is not known in these special populations. 
Farmakokinetika aktivnog metabolita klopidogrela nije poznata za sljedeće posebne populacije bolesnika.
Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction): clopidogrel treatment should be initiated with a single 300 mg loading dose and then continued at 75 mg once a day (with acetylsalicylic acid (ASA) 
Akutni koronarni sindrom bez elevacije ST-segmenta (nestabilna angina ili non-Q infarkt miokarda): liječenje klopidogrelom treba započeti s jednokratnom udarnom dozom od 300 mg, a zatim nastaviti sa 75 mg jedanput dnevno (uz acetilsalicilatnu kiselinu (ASK) 75 mg do 325 mg dnevno).
Acute liver failure, hepatitis, abnormal liver function test 
Poremećaji jetre i žuči akutno zatajenje jetre, hepatitis, abnormalni nalazi pretraga jetrene funkcije
Cellulose, microcrystalline (E460) Crospovidone type A Castor oil, hydrogenated 
Jezgra tablete: makrogol 6000 celuloza, mikrokristalična (E460) krospovidon, tip A hidrogenirano ricinusovo ulje
If you forget for more than 12 hours, simply take the next single dose at the usual time. 
Ukoliko se ne sjetite propuštene doze a prošlo je više od 12 sati, uzmite jednu sljedeću dozu u uobičajeno vrijeme.
However, if you are concerned by your bleeding, you should contact your doctor straightaway (see section 4). 
Ukoliko ste ipak zabrinuti zbog krvarenja, odmah obavijestite svog liječnika (pogledajte dio 4.).
It also contains hydrogenated castor oil. 
POPIS POMOĆNIH TVARI Također sadrži hidrogenirano ricinusovo ulje.
If you become pregnant while taking Clopidogrel Acino, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant. 
Acino, odmah se posavjetujte s liječnikom, jer nije preporučeno uzimati klopidogrel za vrijeme trudnoće.
ST segment elevation acute myocardial infarction: clopidogrel should be given as a single daily dose of 75 mg initiated with a 300 mg loading dose in combination with ASA and with or without thrombolytics. 
Akutni infarkt miokarda s elevacijom ST-segmenta: liječenje klopidogrelom provodi se jednom dnevnom dozom od 75 mg, a započinje udarnom dozom od 300 mg u kombinaciji s ASK te sa ili bez trombolitika.
Experience is limited in patients with moderate hepatic disease who may have bleeding diatheses. 
Ograničeno je iskustvo u bolesnika s umjereno narušenom funkcijom jetre koji bi mogli imati hemoragijsku dijatezu.
Clopidogrel Acino 75 mg 
16. PODACI NA BRAILLOVOM PISMU Klopidogrel Acino 75 mg
An appropriate dose regimen for this patient population has not been established in clinical outcome trials. 
U studijama kliničkog ishoda nije utvrđen odgovarajući režim doziranja za ovu populaciju bolesnika.
In a subgroup analysis by qualifying condition (myocardial infarction, ischaemic stroke, and PAD) the benefit appeared to be strongest (achieving statistical significance at p=0.003) in patients enrolled due to PAD (especially those who also had a history of myocardial infarction) (RRR = 23.7%; CI: 8.9 to 36.2) and weaker (not significantly different from ASA) in stroke patients (RRR = 7.3%; CI: -5.7 to 18.7 [p=0.258]). 
U analizi podskupina sačinjenih prema stanju (infarkt miokarda, ishemijski moždani udar, BPA) činilo se da najveću su korist od liječenja (postignuta statistička značajnost pri p = 0,003) imaju bolesnici s bolešću perifernih arterija (BPA), posebno oni koji su u anamnezi imali infarkt miokarda (RRR = 23,7%; CI: 8,9 do 36,2), a manja korist (ne značajno različita od učinka ASK) uočena je u bolesnika s moždanim udarom (RRR = 7,3%; CI: -5,7 do 18,7 [p=0,258]).
Platelet aggregation induced by agonists other than ADP is also inhibited by blocking the amplification of platelet activation by released ADP. 
Klopidogrel, također inhibira agregaciju trombocita induciranu drugim agonistima, pored ADP-a i to blokiranjem amplifikacije aktivacije trombocita oslobođenim ADP-om.
NAME OF THE MEDICINAL PRODUCT Clopidogrel Acino 75 mg film-coated tablets 
NAZIV LIJEKA Klopidogrel Acino 75 mg filmom obložene tablete
Ethylcellulose (E462) Titanium dioxide (E 171) 
Film ovojnica: makrogol 6000 etilceluloza (E462) titanijev dioksid (E171)
As a precaution concomitant use of strong or moderate CYP2C19 inhibitors should be discouraged (see section 4.5 for a list of CYP2C19 inhibitors, see also section 5.2). 
Kao mjera opreza, ne preporučuje se istodobna primjena lijekova koji su jaki ili umjereni inhibitori CYP2C19 (za popis inhibitora CYP2C19 vidjeti dio 4.5., također vidjeti dio 5.2).
Within less than 12 hours after regular scheduled time: patients should take the dose immediately and then take the next dose at the regular scheduled time. 
Propuštena doza: - Ako je prošlo manje od 12 sati nakon uobičajenog termina uzimanja lijeka: bolesnik treba odmah uzeti dozu, a sljedeću dozu treba uzeti prema uobičajenom rasporedu.
Excipients Clopidogrel Acino contains hydrogenated castor oil which may cause stomach upset and diarrhoea. 
Klopidogrel Acino sadrži hidrogenirano ricinusovo ulje koje može uzrokovati probavne tegobe i proljev.
Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). 
• bolesnika koji boluju od akutnog koronarnog sindroma: - Akutni koronarni sindrom bez elevacije ST-segmenta (nestabilna angina ili non-Q infarkt miokarda), uključujući bolesnike koji se podvrgavaju ugradnji stenta nakon perkutane koronarne intervencije, u kombinaciji s acetilsalicilatnom kiselinom (ASK).
Patients received clopidogrel (300 mg loading dose, followed by 75 mg/day, n=1752) or placebo (n=1,739), both in combination with ASA (150 to 325 mg as a loading dose, followed by 75 to 162 mg/day), a fibrinolytic agent and, when appropriate, heparin. 
Bolesnici su primali klopidogrel (najprije udarnu dozu od 300 mg, a nakon toga dozu od 75 mg na dan, n=1752) ili placebo (n=1739), oboje u kombinaciji s ASK (150 do 325 mg kao udarna doza nakon čega je slijedila doza od 75 do 162 mg na dan), fibrinolitik i, po potrebi, heparin.
Driving and using machines Clopidogrel Acino is unlikely to affect your ability to drive or to use machines. 
Acino ne bi trebao utjecati na Vašu sposobnost upravljanja vozilima ili strojevima.
The number of patients experiencing the primary endpoint [cardiovascular (CV) death, myocardial infarction (MI), or stroke] was 582 (9.3%) in the clopidogrel-treated group and 719 (11.4%) in the placebo-treated group, a 20% relative risk reduction (95% CI of 10%-28%; p=0.00009) for the clopidogrel-treated group (17% relative risk reduction when patients were treated conservatively, 29% when they underwent percutaneous transluminal coronary angioplasty (PTCA) with or without stent and 10% when they underwent coronary artery bypass graft (CABG). 
Broj bolesnika koji su doživjeli primarni ishod [kardiovaskularna smrt, infarkt miokarda ili moždani udar] bio je 582 (9,3%) u skupini koja je primala klopidogrel i 719 (11,4%) u skupini koja je primala placebo, uz 20%-tno smanjenje relativnog rizika (95% CI od 10% do 28%; p=0,00009) u skupini koja se liječila klopidogrelom (17% smanjenje relativnoga rizika u bolesnika koji su liječeni konzervativno, 29% u bolesnika podvrgnutih perkutanoj transluminalnoj koronarnoj angioplastici (PTCA) s ili bez ugradnje stenta i 10% za bolesnike kojima je obavljeno aortokoronarno premoštenje (CABG, engl.
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus 
Poremećaji kože i potkožnog tkiva bulozni dermatitis (toksična epidermalna nekroliza, Stevens Johnsonov sindrom, erythema multiforme, akutna generalizirana egzantematozna pustuloza (AGEP)), angioedem, sindrom preosjetljivosti izazvan lijekom, osip uzrokovan lijekom s eozinofilijom i sistemskim simptomima (engl.
Clopidogrel Acino contains hydrogenated castor oil May cause stomach upset or diarrhoea. 
Klopidogrel Acino sadrži hidrogenirano ricinusovo ulje Može uzrokovati želučane tegobe i proljev.
Cellulose, microcrystalline (E460) 
Jezgra tablete: makrogol 6000 celuloza, mikrokristalična (E460)
What you need to know before you take Clopidogrel Acino 
Što morate znati prije nego počnete uzimati Klopidogrel Acino Nemojte uzimati Klopidogrel
Major bleeding was mostly of extracranial origin in both groups (5.3% in the clopidogrel + ASA group; 3.5% in the placebo +ASA group), mainly from the gastrointestinal tract (3.5% vs. 1.8%). 
Velika krvarenja su najčešće bila ekstrakranijalnog porijekla u obje skupine (5,3% u skupini klopidogrel + ASK; 3,5% u skupini placebo + ASK),
Clopidogrel Acino 75 mg film-coated tablets Clopidogrel 
Klopidogrel Acino 75 mg filmom obložene tablete klopidogrel